Pricing

DMK Pharmaceuticals Corp (DMKPQ)

followers ·
Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
David J. Marguglio
Employees:
20
11682 EL CAMINO REAL, SUITE 300, SAN DIEGO, CA, 92130
(858) 997-2400
Stock Split History
DateRatio
2013-12-13 1:17
2023-05-22 1:70
Adamis Pharmaceuticals Corporation develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease. The company's product candidates comprise SYMJEPI epinephrine pre-filled syringe injectable products for use in the emergency treatment of acute allergic reactions, including anaphylaxis.
All 13F Filers Prior Change Hedge Funds 1 Prior Change
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available